| Estimating Alzheimer's disease progression rates from normal cognition through mild cognitive impairment and stages of dementia M Davis, T O'Connell, S Johnson, S Cline, E Merikle, F Martenyi, ... Current Alzheimer Research 15 (8), 777-788, 2018 | 154 | 2018 |
| The cost of disability and medically related absenteeism among employees with multiple sclerosis in the US JI Ivanova, HG Birnbaum, S Samuels, M Davis, AL Phillips, D Meletiche Pharmacoeconomics 27, 681-691, 2009 | 91 | 2009 |
| Risk of developing comorbidities among women with endometriosis: a retrospective matched cohort study ES Surrey, AM Soliman, SJ Johnson, M Davis, J Castelli-Haley, ... Journal of women's health 27 (9), 1114-1123, 2018 | 88 | 2018 |
| Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis … DT Rubin, M Mittal, M Davis, S Johnson, J Chao, M Skup Journal of Managed Care & Specialty Pharmacy, 2017 | 81 | 2017 |
| Direct costs and survival of medicare beneficiaries with early and advanced Parkinson’s disease A Kaltenboeck, SJ Johnson, MR Davis, HG Birnbaum, CA Carroll, ... Parkinsonism & related disorders 18 (4), 321-326, 2012 | 72 | 2012 |
| Impact of increasing adherence to disease-modifying therapies on healthcare resource utilization and direct medical and indirect work loss costs for patients with multiple … S Yermakov, M Davis, M Calnan, M Fay, B Cox-Buckley, S Sarda, MS Duh, ... Journal of medical economics 18 (9), 711-720, 2015 | 64 | 2015 |
| Reintervention rates after myomectomy, endometrial ablation, and uterine artery embolization for patients with uterine fibroids MR Davis, AM Soliman, J Castelli-Haley, MC Snabes, ES Surrey Journal of women's health 27 (10), 1204-1214, 2018 | 57 | 2018 |
| Patient support program increased medication adherence with lower total health care costs despite increased drug spending D Brixner, DT Rubin, P Mease, M Mittal, H Liu, M Davis, A Ganguli, ... Journal of managed care & specialty pharmacy 25 (7), 770-779, 2019 | 45 | 2019 |
| Healthcare costs and utilization for privately insured patients treated for non-infectious uveitis in the USA DS Chu, SJ Johnson, UG Mallya, MR Davis, RA Sorg, MS Duh Journal of Ophthalmic Inflammation and Infection 3, 1-10, 2013 | 38 | 2013 |
| Early retirement and income loss in patients with early and advanced Parkinson’s disease S Johnson, M Davis, A Kaltenboeck, H Birnbaum, EB Grubb, M Tarrants, ... Applied Health Economics and Health Policy 9, 367-376, 2011 | 34 | 2011 |
| Economic impact of multiple sclerosis disease-modifying drugs in an employed population: direct and indirect costs HG Birnbaum, JI Ivanova, S Samuels, M Davis, PY Cremieux, AL Phillips, ... Current medical research and opinion 25 (4), 869-877, 2009 | 32 | 2009 |
| Effects of non-medical switching on outcomes among patients prescribed tumor necrosis factor inhibitors A Gibofsky, M Skup, M Mittal, SJ Johnson, M Davis, J Chao, DT Rubin Current medical research and opinion 33 (11), 1945-1953, 2017 | 19 | 2017 |
| Participation in an innovative patient support program reduces prescription abandonment for adalimumab-treated patients in a commercial population D Brixner, M Mittal, DT Rubin, P Mease, HH Liu, M Davis, A Ganguli, ... Patient preference and adherence, 1545-1556, 2019 | 14 | 2019 |
| Changes in healthcare spending after diagnosis of comorbidities among endometriosis patients: a difference-in-differences analysis AJ Epstein, AM Soliman, M Davis, SJ Johnson, MC Snabes, ES Surrey Advances in therapy 34, 2491-2502, 2017 | 13 | 2017 |
| Direct medical costs of dementia with Lewy bodies by disease complexity R Espinosa, M Davis, S Johnson, S Cline, D Weintraub Journal of the American Medical Directors Association 21 (11), 1696-1704. e5, 2020 | 10 | 2020 |
| Rotavirus vaccination in a Medicaid infant population from four US states: compliance, vaccination completion rate, and predictors of compliance M Calnan, G Krishnarajah, MS Duh, BA Haider, S Yermakov, M Davis, ... Human Vaccines & Immunotherapeutics 12 (5), 1235-1243, 2016 | 10 | 2016 |
| Cost-analysis model of colonoscopy preparation using split-dose reduced-volume oral sulfate solution (OSS) and polyethylene glycol with electrolytes solution (PEG-ELS) L Huynh, S Yermakov, M Davis, R Campbell, M Cleveland, FA Farraye, ... Journal of Medical Economics 19 (4), 356-363, 2016 | 10 | 2016 |
| Impact of Abbvie's Patient Support Program on Resource Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing … DT Rubin, M Skup, M Davis, S Johnson, J Chao Arthritis & Rheumatology 67, 2820-2821, 2015 | 8 | 2015 |
| Sustained long-term benefits of patient support program participation in immune-mediated diseases: improved medication-taking behavior and lower risk of a hospital visit AM Fendrick, D Brixner, DT Rubin, P Mease, H Liu, M Davis, M Mittal Journal of Managed Care & Specialty Pharmacy 27 (8), 1086-1095, 2021 | 6 | 2021 |
| Impact of early initiation of eslicarbazepine acetate on economic outcomes among patients with focal seizure: results from retrospective database analyses D Mehta, M Davis, AJ Epstein, B Wensel, T Grinnell, GR Williams Neurology and Therapy 9, 585-598, 2020 | 6 | 2020 |
